Falseflax may hold key

Reading Time: 2 minutes

Published: November 1, 2001

There might be a compromise for those who want genetically modified flax and those who don’t.

Agriculture Canada scientist Richard Gugel says Camelina sativa, also known as falseflax, could make a good delivery vehicle for researchers trying to produce compounds such as pharmaceuticals and plastics in oilseeds.

“It seems to have a lot going for it.”

While commonly thought of as a weed in North America, falseflax is an oilseed that shows potential as a candidate for genetic modification.

Most research into developing an oilseed that can be used to create biodegradable plastic and pharmaceuticals has so far focused on canola.

Read Also

Close-up of some ripe pinto beans on the plant.

Dry bean seeded acreage in Manitoba hits 20-year high

Dry bean acreage across all types reached around 207,000 acres in 2025, representing a significant increase from last year’s 182,000 acres.

Some scientists think flax is better suited than canola to genetic modification because it is primarily used to produce industrial products.

But flax growers don’t want GM flax introduced into Canada’s production system. They successfully fought the introduction of CDC Triffid and say they will resist other GM varieties – at least until the Europeans soften their stance on GMOs.

Falseflax may be the answer to both concerns. While it is similar to flax and other oilseeds, it doesn’t look the same and would be easy to keep separate.

“You see it, you know it. It is visually distinct,” Gugel said.”If you see it you know – do not eat.”

The crop is resistant to many of the disease and insect pests that plague canola. As well, one year of trials in Saskatoon had yields that compared well to canola and mustard.

Aside from last year’s yield trials, little research has been done on the crop. For instance, scientists don’t know its soil fertility requirements or what herbicides would work with it. They do know the seed size is small and could cause harvesting problems.

The Plant Biotechnology Institute is working with the crop, but more pathology and GM research is required before researchers will suggest using the crop to produce high-value industrial chemicals.

“We’re just scratching the surface here,” Gugel said.

About the author

Sean Pratt

Sean Pratt

Reporter/Analyst

Sean Pratt has been working at The Western Producer since 1993 after graduating from the University of Regina’s School of Journalism. Sean also has a Bachelor of Commerce degree from the University of Saskatchewan and worked in a bank for a few years before switching careers. Sean primarily writes markets and policy stories about the grain industry and has attended more than 100 conferences over the past three decades. He has received awards from the Canadian Farm Writers Federation, North American Agricultural Journalists and the American Agricultural Editors Association.

explore

Stories from our other publications